{
    "xml": "<topic id=\"PHP6347\" outputclass=\"drug\" rev=\"1.11\" type=\"drug\" namespace=\"/drugs/betaine\" basename=\"betaine\" title=\"BETAINE\">\n<title>BETAINE</title>\n<body>\n<data name=\"vtmid\">413645006</data>\n<data name=\"classifications\">\n<data name=\"classification\">\n<data name=\"drugClassification\">\n<xref format=\"dita\" scope=\"local\" type=\"drugClassification\" href=\"#_668154464\" title=\"Methyl donors\">Methyl donors</xref>\n</data>\n</data>\n</data>\n<data name=\"primaryDomainOfEffect\">\n<data name=\"domainOfEffect\">  </data>\n</data>\n</body>\n<topic id=\"PHP35440\" outputclass=\"indicationsAndDose\" rev=\"1.30\" parent=\"/drugs/betaine\">\n<title>Indications and dose</title>\n<body>\n<section outputclass=\"indicationAndDoseGroup\">\n<sectiondiv outputclass=\"therapeuticIndications\">\n<p outputclass=\"therapeuticIndication\">Adjunctive treatment of homocystinuria involving deficiencies or defects in cystathionine beta-synthase, 5,10-methylene-tetrahydrofolate reductase, or cobalamin cofactor metabolism (specialist use only)</p>\n</sectiondiv>\n<p outputclass=\"routesOfAdministration\">By mouth</p>\n<ul outputclass=\"patientGroups\">\n<li outputclass=\"patientGroup adult\">\n<p>Adult</p>\n<p>3&#8239;g twice daily (max. per dose 10&#8239;g), adjusted according to response; maximum 20&#8239;g per day.</p>\n</li>\n</ul>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35408\" outputclass=\"sideEffects\" rev=\"1.14\" parent=\"/drugs/betaine\">\n<title>Side-effects</title>\n<body>\n<section outputclass=\"generalSideEffects\">\n<sectiondiv outputclass=\"frequencies\">\n<sectiondiv outputclass=\"uncommon\">\n<p outputclass=\"title\">Uncommon</p>\n<p outputclass=\"sideEffects\">\n<ph outputclass=\"sideEffect\">Agitation</ph>; <ph outputclass=\"sideEffect\">alopecia</ph>; <ph outputclass=\"sideEffect\">anorexia</ph>; <ph outputclass=\"sideEffect\">depression</ph>; <ph outputclass=\"sideEffect\">gastro-intestinal disorders</ph>; <ph outputclass=\"sideEffect\">personality disorder</ph>; <ph outputclass=\"sideEffect\">reversible cerebral oedema</ph>; <ph outputclass=\"sideEffect\">sleep disturbances</ph>; <ph outputclass=\"sideEffect\">urinary incontinence</ph>; <ph outputclass=\"sideEffect\">urticaria</ph>\n</p>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35431\" outputclass=\"pregnancy\" parent=\"/drugs/betaine\">\n<title>Pregnancy</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises avoid unless essential&#8212;limited information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35467\" outputclass=\"breastFeeding\" parent=\"/drugs/betaine\">\n<title>Breast feeding</title>\n<body>\n<section outputclass=\"generalInformation\">\n<sectiondiv>\n<p>Manufacturer advises caution&#8212;no information available.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35388\" outputclass=\"monitoringRequirements\" parent=\"/drugs/betaine\">\n<title>Monitoring requirements</title>\n<body>\n<section outputclass=\"monitoringOfPatientParameters\">\n<sectiondiv>\n<p>Monitor plasma-methionine concentration before and during treatment&#8212;interrupt treatment if symptoms of cerebral oedema occur.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35473\" outputclass=\"directionsForAdministration\" rev=\"1.10\" parent=\"/drugs/betaine\">\n<title>Directions for administration</title>\n<body>\n<section>\n<sectiondiv>\n<p>Powder should be mixed with water, juice, milk, formula, or food until completely dissolved and taken immediately; measuring spoons are provided to measure 1&#8239;g, 150&#8239;mg, and 100&#8239;mg of <i>Cystadane</i>\n<tm tmtype=\"reg\"/> powder.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP60761\" outputclass=\"prescribingAndDispensingInformation\" rev=\"1.8\" parent=\"/drugs/betaine\">\n<title>Prescribing and dispensing information</title>\n<body>\n<section>\n<sectiondiv>\n<p>Betaine should be used in conjunction with dietary restrictions and may be given with supplements of Vitamin B<sub>12</sub>, pyridoxine, and folate under specialist advice.</p>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP35374\" outputclass=\"nationalFunding\" rev=\"1.9\" parent=\"/drugs/betaine\">\n<title>National funding/access decisions</title>\n<body>\n<section>\n<sectiondiv outputclass=\"smcDecisions\">\n<p outputclass=\"title\">Scottish Medicines Consortium (SMC) Decisions</p>\n<sectiondiv outputclass=\"smcDecision\">\n<sectiondiv>\n<p>The <i>Scottish Medicines Consortium</i> has advised (July 2010) that betaine anhydrous (Cystadane<tm tmtype=\"reg\"/>) is accepted for restricted use within NHS Scotland for the adjunctive treatment of homocystinuria involving deficiencies or defects in cystathionine beta-synthase, 5,10-methylene-tetrahydrofolate reductase, or cobalamin cofactor metabolism in patients who are not responsive to pyridoxine treatment.</p>\n</sectiondiv>\n</sectiondiv>\n</sectiondiv>\n</section>\n</body>\n</topic>\n<topic id=\"PHP6347-medicinalForms\" outputclass=\"medicinalForms\" parent=\"/drugs/betaine\">\n<title>Medicinal forms</title>\n<body>\n<section outputclass=\"licensingVariationStatement\">\n<p>There can be variation in the licensing of different medicines containing the same drug.</p>\n</section>\n<p>Forms available from special-order manufacturers include: oral solution, tablet</p>\n</body>\n</topic>\n<parents>\n<xref format=\"dita\" scope=\"local\" type=\"drugs\" href=\"#drugs\" title=\"Drugs\" namespace=\"/drugs\">Drugs</xref>\n</parents>\n<children>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77548\" title=\"Powder\" namespace=\"/drugs/betaine/powder\">Powder</xref>\n</children>\n<backlinks>\n<xref format=\"dita\" scope=\"local\" type=\"drugClassifications\" href=\"#PHP106980\" namespace=\"/drug-classifications\" title=\"Drug classifications\" count=\"1\" rel=\"backlink\">Drug classifications</xref>\n</backlinks>\n<links>\n<xref format=\"dita\" scope=\"local\" type=\"#drugs\" href=\"#drugs\" namespace=\"/drugs\" title=\"Drugs\" count=\"1\" rel=\"link\">Drugs</xref>\n<xref format=\"dita\" scope=\"local\" type=\"medicinalForm\" href=\"#PHP77548\" namespace=\"/drugs/betaine/powder\" title=\"Powder\" count=\"1\" rel=\"link\">Powder</xref>\n</links>\n</topic>",
    "id": "PHP6347",
    "outputclass": "drug",
    "rev": "1.11",
    "type": "drug",
    "namespace": "/drugs/betaine",
    "basename": "betaine",
    "title": "BETAINE",
    "vtmid": "413645006",
    "drugClassification": [
        "Methyl donors"
    ],
    "primaryDomainOfEffect": {
        "": {
            "domain": "",
            "therapeuticUses": {}
        }
    },
    "indicationsAndDoses": {
        "indicationAndDoseGroups": [
            {
                "indications": [
                    {
                        "textContent": "Adjunctive treatment of homocystinuria involving deficiencies or defects in cystathionine beta-synthase, 5,10-methylene-tetrahydrofolate reductase, or cobalamin cofactor metabolism (specialist use only)",
                        "html": "Adjunctive treatment of homocystinuria involving deficiencies or defects in cystathionine beta-synthase, 5,10-methylene-tetrahydrofolate reductase, or cobalamin cofactor metabolism (specialist use only)"
                    }
                ],
                "specificity": {
                    "routes": [
                        "mouth"
                    ],
                    "textContent": "By mouth",
                    "html": "By mouth"
                },
                "adult": [
                    {
                        "textContent": "3 g twice daily (max. per dose 10 g), adjusted according to response; maximum 20 g per day.",
                        "html": "<p>3&#8239;g twice daily (max. per dose 10&#8239;g), adjusted according to response; maximum 20&#8239;g per day.</p>"
                    }
                ]
            }
        ]
    },
    "sideEffects": {
        "general": {
            "frequencies": {
                "uncommon": [
                    {
                        "type": "uncommon",
                        "textContent": "Agitation",
                        "html": "Agitation",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "alopecia",
                        "html": "alopecia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "anorexia",
                        "html": "anorexia",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "depression",
                        "html": "depression",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "gastro-intestinal disorders",
                        "html": "gastro-intestinal disorders",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "personality disorder",
                        "html": "personality disorder",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "reversible cerebral oedema",
                        "html": "reversible cerebral oedema",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "sleep disturbances",
                        "html": "sleep disturbances",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "urinary incontinence",
                        "html": "urinary incontinence",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    },
                    {
                        "type": "uncommon",
                        "textContent": "urticaria",
                        "html": "urticaria",
                        "frequency": "uncommon",
                        "specificity": {
                            "textContent": "Uncommon",
                            "html": "Uncommon"
                        }
                    }
                ]
            }
        }
    },
    "pregnancy": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises avoid unless essential&#8212;limited information available.",
                "html": "<p>Manufacturer advises avoid unless essential&#8212;limited information available.</p>"
            }
        ]
    },
    "breastFeeding": {
        "generalInformation": [
            {
                "type": "generalInformation",
                "textContent": "Manufacturer advises caution&#8212;no information available.",
                "html": "<p>Manufacturer advises caution&#8212;no information available.</p>"
            }
        ]
    },
    "monitoringRequirements": {
        "patientParameters": [
            {
                "type": "patientParameters",
                "textContent": "Monitor plasma-methionine concentration before and during treatment&#8212;interrupt treatment if symptoms of cerebral oedema occur.",
                "html": "<p>Monitor plasma-methionine concentration before and during treatment&#8212;interrupt treatment if symptoms of cerebral oedema occur.</p>"
            }
        ]
    },
    "directionsForAdministration": {
        "directionsForAdministration": [
            {
                "type": "directionsForAdministration",
                "textContent": "Powder should be mixed with water, juice, milk, formula, or food until completely dissolved and taken immediately; measuring spoons are provided to measure 1 g, 150 mg, and 100 mg of Cystadane powder.",
                "html": "<p>Powder should be mixed with water, juice, milk, formula, or food until completely dissolved and taken immediately; measuring spoons are provided to measure 1&#8239;g, 150&#8239;mg, and 100&#8239;mg of <i>Cystadane</i>\n<tm tmtype=\"reg\"/> powder.</p>"
            }
        ]
    },
    "prescribingAndDispensingInformation": {
        "prescribingAndDispensingInformation": [
            {
                "type": "prescribingAndDispensingInformation",
                "textContent": "Betaine should be used in conjunction with dietary restrictions and may be given with supplements of Vitamin B12, pyridoxine, and folate under specialist advice.",
                "html": "<p>Betaine should be used in conjunction with dietary restrictions and may be given with supplements of Vitamin B<sub>12</sub>, pyridoxine, and folate under specialist advice.</p>"
            }
        ]
    },
    "nationalFunding": {
        "smcDecisions": [
            {
                "type": "smcDecisions",
                "textContent": "The Scottish Medicines Consortium has advised (July 2010) that betaine anhydrous (Cystadane) is accepted for restricted use within NHS Scotland for the adjunctive treatment of homocystinuria involving deficiencies or defects in cystathionine beta-synthase, 5,10-methylene-tetrahydrofolate reductase, or cobalamin cofactor metabolism in patients who are not responsive to pyridoxine treatment.",
                "html": "<p>The <i>Scottish Medicines Consortium</i> has advised (July 2010) that betaine anhydrous (Cystadane<tm tmtype=\"reg\"/>) is accepted for restricted use within NHS Scotland for the adjunctive treatment of homocystinuria involving deficiencies or defects in cystathionine beta-synthase, 5,10-methylene-tetrahydrofolate reductase, or cobalamin cofactor metabolism in patients who are not responsive to pyridoxine treatment.</p>"
            }
        ]
    },
    "medicinalForms": {
        "licensingVariationStatement": [
            {
                "type": "licensingVariationStatement",
                "textContent": "There can be variation in the licensing of different medicines containing the same drug.",
                "html": "<p>There can be variation in the licensing of different medicines containing the same drug.</p>"
            }
        ],
        "availableForms": {
            "before": "Forms available from special-order manufacturers include",
            "forms": [
                "oral solution",
                "tablet"
            ]
        }
    },
    "children": {
        "medicinalForm": [
            {
                "id": "PHP77548",
                "label": "Powder",
                "type": "medicinalForm"
            }
        ]
    },
    "backlinks": {
        "drugClassifications": [
            {
                "id": "PHP106980",
                "label": "Drug classifications",
                "type": "drugClassifications"
            }
        ]
    },
    "links": {
        "#drugs": [
            {
                "id": "drugs",
                "label": "Drugs",
                "type": "#drugs"
            }
        ],
        "medicinalForm": [
            {
                "id": "PHP77548",
                "label": "Powder",
                "type": "medicinalForm"
            }
        ]
    }
}